FOUNDED IN 1859 BY QUEEN EMMA AND KING KAMEHAMEHA IV
Menu
Office of Research and Development
Office of Research and Development
The Queen’s Medical Center
1301 Punchbowl Street, UHT 508
Honolulu, Hawaii 96813
FOUNDED IN 1859 BY QUEEN EMMA AND KING KAMEHAMEHA IV
Office of Research and Development
Office of Research and Development
The Queen’s Medical Center
1301 Punchbowl Street, UHT 508
Honolulu, Hawaii 96813
The Clinical Trials Office is a group of highly trained, experienced research nurses and administrative support staff, whose primary role is to support physicians conducting clinical trials. The Clinical Trials Office has participated in Phase I, II, III and IV trials. The trials have originated from pharmaceutical sponsors, the National Cancer Institute, joint studies with other medical institutions, and investigator-initiated trials.
Our support services include:
If you would like more information about utilizing the services of the Clinical Trials Office, please contact:
Todd Seto, M.D.
Medical Director, Clinical Trials Office
1301 Punchbowl Street
Honolulu, Hawaii 96813
Phone: 808.691.4539
E-mail: [email protected]
Investigators may use their own experienced research staff to assist them in their studies. Or, investigators may wish to use the services of the Clinical Trials Office, including:
The Queen’s Medical Center
Office of Research and Development
1301 Punchbowl Street
UHT 508
Honolulu, Hawaii 96813
Copyright 1999-2023. Office of Research and Development, The Queen’s Medical Center. Disclaimer
RE: DECLARATION OF PROCUREMENT STANDARDS
The Queen’s Medical Center (QMC) hereby elects to utilize the grace period established in the Office of Management & Budget Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards; final Rule – 2 CFR Chapter I, Chapter II, Part 200, et al. also known as the Uniform Guidance (UG) for July 1, 2015 (FY 16) and continue use of Circular A-110.
Excerpt from § 200.110 (a): “For the procurement standards in §§ 200.317 – 200.326, non-Federal entities may continue to comply with the procurement standards in previous OMB guidance (superseded by this part as described in § 200.104) for two additional fiscal years after this part goes into effect. If a non-Federal entity chooses to use the previous procurement standards for two additional fiscal years before adopting the procurement standards in this part, the non-Federal entity must document this decision in their internal procurement policies.”
In the meantime, QMC shall modify and develop procurement procedures to become consistent with the Uniform Guidance. QMC shall be in compliance with the UG effective July 1, 2018 (FY 19).